Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Affymetrix Gene Chip Users

Council Members in this Study Group: 77

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Gregory Khitrov, Director of Personalized Medicine Program, MOUNT SINAI SCHOOL OF MEDICINE OFGregory Khitrov

Director of Personalized Medicine Program
MOUNT SINAI SCHOOL OF MEDICINE OF
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Greg Khitrov, PhD, is the Director of Institutes for Personalized Medicine Core Laboratory, Director of Biobank and an Assistant Professor of Medicine at the Mount Sinai School of Medicine in New York. He has expertise in molecular biology; proteomics;...

Richard Wilson

Professor of Genetics and Molecular Microbiology
THE WASHINGTON UNIVERSITY
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Richard Wilson, PhD, is Professor of Genetics and Molecular Microbiology at Washington University School of Medicine in St. Louis, Missouri. Additionally, Dr. Wilson is Director of the Genome Sequencing Center and a Research Member of the Siteman Cancer...

Steve Perrin

Chief Scientific Officer
ALS Therapy Development Institute
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Steve Perrin, PhD, is Chief Scientific Officer of ALS Therapy Development Institute. Dr. Perrin is responsible for all aspects of the Research and Development organization. The goal of the Institute is to identify and develop new therapeutic candidates...

GLG NewsSM Analyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

the way to go, the alternative fuil future is now

March 19, 2009

Toyota to develop affordable hybrid vehicle | www.marketwatch.com

Starting to work on slowing down our dependence on foreign oil

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Academic Institution*
  • Research Foundation
  • Biotechnology Manufacturer
  • Pharmaceuticals Manufacturer

Members in this Study Group often have these job titles:

  • Director
  • Research Scientist
  • Physician - Attending Physician
  • Professor
  • Physician - Director
  • Physician - Department Chair
  • Researcher

GLG Live Meetings with this Study Group's Leading Experts (?)

January 29, 2009 | Boston

GLG Seminar: (BOS) Next Generation Sequencing with Richard Wilson, PhD

April 26, 2007 | New York

GLGi: Genotyping Technologies

GLG Webcasts & Teleconferences

Leading Experts in Affymetrix Gene Chip Users have not participated in any GLG webcasts.

View All GLG Webcasts & Teleconferences in Healthcare